Tumorigenesis: Transcriptional elongation and cancer

Current Biology

Volumn 6, Issue 8, 1996, Pages 943-944

  Li, Xiao Yong ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; NEOPLASM; REVIEW; TUMOR SUPPRESSOR GENE;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 0030208777     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00633-4     Document Type: Article

References (13)

1. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al.: Identification of the von Hippel Lindau disease tumor suppressor gene. Science 1993, 260:1317-1320
2. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995, 269:1402-1406.
3. Kibel A, Lliopoulos O, DeCaprio JA, Kaelin Jr WG: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995, 269:1444-1446.
4. Aso T, Lane WS, Conaway JW, Conaway RC: Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 1995, 269:1439-1443.
5. Lee S, Chen DYT, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD: Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 1996, 93:1770-1775.
6. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD: Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994, 91:12110-12114.
7. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW: An RNA polymerase Il elongation factor encoded by the human ELL gene. Science 1996, 271:1873-1876.
8. Bentley DL: Regulation of transcriptional elongation by RNA polymerase II. Curr Opin Genet Dev 1995, 5:210-216
9. Weeks JR, Hardin SE, Shen J, Lee JM, Greenleaf AL: Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. Genes Dev 1993, 7:2329-2344.
10. Krumm A, Hickey LB, Groudine M: Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev 1995, 9:559-572.
11. Yankulov K, Blau J, Purton T, Roberts S, Bentley DL: Transcription elongation by RNA polymerase II is stimulated by transactivators. Cell 1994, 77:749-759.
12. O'Brien T, Hardin S, Greenleaf A, Lis JT: Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 1994, 370:75-77.
13. Jones KA, Peterlin BM: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994, 63:717-743.